209 related articles for article (PubMed ID: 15757543)
1. [Mucoepidermoid carcinoma of nasopharynx: a report of twelve cases].
Qiu F; Hua YJ; Guo L; He JH; Qiu XL; Hong MH
Ai Zheng; 2005 Mar; 24(3):362-4. PubMed ID: 15757543
[TBL] [Abstract][Full Text] [Related]
2. A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer.
Guo ZM; Liu WW; He JH
Clin Otolaryngol; 2009 Aug; 34(4):322-7. PubMed ID: 19673979
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of sixteen cases of lymphoepithelial carcinoma of salivary gland].
Zhang Q; Qing J; Wei MW; Guo ZM
Ai Zheng; 2005 Nov; 24(11):1384-7. PubMed ID: 16552968
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with positive Epstein-Barr virus serologic status in the absence of nasopharyngeal carcinoma in Hong Kong.
Lo S; Ho WK; Wei WI
Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):770-2. PubMed ID: 15210561
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus (EBV) serology for predicting distant metastases in a white juvenile patient with nasopharyngeal carcinoma and no clinical response to EBV lytic induction therapy.
Stevens SJ; Zwaan CM; Verkuijlen SA; Middeldorp JM
Head Neck; 2006 Nov; 28(11):1040-5. PubMed ID: 16933315
[TBL] [Abstract][Full Text] [Related]
6. [Significance of detection of serum sialic acid and Epstein-Barr virus VCA-IgA in diagnosis and monitoring radiotherapy effectiveness in nasopharyngeal carcinoma patients].
Jiang LN; Dai LC; He JF; Chen YW; Ma ZH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):30-2. PubMed ID: 16816858
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
[TBL] [Abstract][Full Text] [Related]
8. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].
Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY
Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma.
Tang JW; Rohwäder E; Chu IM; Tsang RK; Steinhagen K; Yeung AC; To KF; Chan PK
J Clin Virol; 2007 Dec; 40(4):284-8. PubMed ID: 17977062
[TBL] [Abstract][Full Text] [Related]
10. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
[TBL] [Abstract][Full Text] [Related]
11. Primary salivary gland-type carcinomas of the nasopharynx: prognostic factors and outcome.
Cao CN; Zhang XM; Luo JW; Xu GZ; Gao L; Li SY; Xiao JP; Yi JL; Huang XD; Liu SY; Xu ZG; Tang PZ
Int J Oral Maxillofac Surg; 2012 Aug; 41(8):958-64. PubMed ID: 22579955
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842
[TBL] [Abstract][Full Text] [Related]
13. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.
Hsu WL; Chen JY; Chien YC; Liu MY; You SL; Hsu MM; Yang CS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1218-26. PubMed ID: 19336547
[TBL] [Abstract][Full Text] [Related]
14. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal carcinoma in situ (NPCIS)--pathologic and clinical perspectives.
Pak MW; To KF; Lo YM; Chan LY; Tong JH; Lo KW; van Hasselt CA
Head Neck; 2002 Nov; 24(11):989-95. PubMed ID: 12410533
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis and long-term follow up study of asymptomatic nasopharyngeal carcinoma patients].
Ji MF; Guo YQ; Zheng SA; Liang JS; Wang DK; Ou XT
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):53-6. PubMed ID: 12778770
[TBL] [Abstract][Full Text] [Related]
17. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
18. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
Kalpoe JS; Dekker PB; van Krieken JH; Baatenburg de Jong RJ; Kroes AC
J Clin Pathol; 2006 May; 59(5):537-41. PubMed ID: 16489178
[TBL] [Abstract][Full Text] [Related]
19. The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma.
Chang KP; Hao SP; Lin SY; Ueng SH; Pai PC; Tseng CK; Hsueh C; Hsieh MS; Yu JS; Tsang NM
Laryngoscope; 2006 Apr; 116(4):541-6. PubMed ID: 16585856
[TBL] [Abstract][Full Text] [Related]
20. Different therapeutic strategies in primary salivary gland-type nasopharyngeal carcinomas.
Liu TR; Chen FJ; Zhang GP; Yang AK
Curr Opin Otolaryngol Head Neck Surg; 2011 Apr; 19(2):87-91. PubMed ID: 21297475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
